Clinical trials
Phase 1/2 Autoimmune Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Terminated | 5 |
| Withdrawn | 2 |
| Completed | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cabaletta Bio | 3 |
| Kyverna Therapeutics | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Atara Biotherapeutics | 1 |
| Cullinan Therapeutics Inc. | 1 |
| Eledon Pharmaceuticals | 1 |
| Joseph B. Ciolino, MD | 1 |
| M.D. Anderson Cancer Center | 1 |
| Northwestern University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 20 |
| Immune System Diseases | 5 |
| Lupus Erythematosus, Systemic | 4 |
| Arthritis, Rheumatoid | 3 |
| Lupus Nephritis | 3 |
| Anemia, Aplastic | 2 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Glomerulonephritis | 2 |
| Hypoglycemia | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.